132 related articles for article (PubMed ID: 8432180)
1. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia.
Marvin KS; Spellberg RD
Chest; 1993 Feb; 103(2):642-4. PubMed ID: 8432180
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases.
García-Manero G; Schuster SJ; Patrick H; Martinez J
Am J Hematol; 1999 Feb; 60(2):130-5. PubMed ID: 9929105
[TBL] [Abstract][Full Text] [Related]
3. Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.
Dagorne A; Douet-Guilbert N; Quintin-Roue I; Guillerm G; Couturier MA; Berthou C; Ianotto JC
Ann Hematol; 2013 Mar; 92(3):407-9. PubMed ID: 22941306
[No Abstract] [Full Text] [Related]
4. Left ventricular mural thrombus in a patient with thrombocytosis and agnogenic myeloid metaplasia.
Baker KM; Hess CE; Ayers CR; Johns DW; Mentzer RM; Wellsons HA; Taylor GJ; Martin RP
Arch Intern Med; 1981 Oct; 141(11):1527-9. PubMed ID: 7283566
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-alpha.
Kikawa Y; Fukumoto Y; Obata K; Tamura S; Takeuchi M; Tanizawa A; Mayumi M
J Pediatr Hematol Oncol; 1998; 20(5):463-6. PubMed ID: 9787320
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
Debureaux PE; Brignier A; Soret-Dulphy J; Réa D; Michonneau D; Peffault de Latour R; Sicre de Fontbrune F; Pagliuca S; Parquet N; Prata HP; Marouf A; Xhaard A; Kiladjian JJ; Socié G; Robin M
Ann Hematol; 2020 Apr; 99(4):897-898. PubMed ID: 32030449
[No Abstract] [Full Text] [Related]
7. Leukemia with megakaryocytic differentiation following essential thrombocythemia and myelofibrosis. Case report and review of the literature.
Patiño-Sarcinelli F; Knecht H; Pechet L; Pihan G; Savas L; Snyder LM
Acta Haematol; 1996; 95(2):122-8. PubMed ID: 8638441
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension associated with long-standing thrombocytosis.
Rostagno C; Prisco D; Abbate R; Poggesi L
Chest; 1991 May; 99(5):1303-5. PubMed ID: 1826875
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia.
Hill G; McClean D; Fraser R; Hart D; Crozier I; Snowden J; Gibbons S
Aust N Z J Med; 1996 Dec; 26(6):852-3. PubMed ID: 9028525
[No Abstract] [Full Text] [Related]
11. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
[TBL] [Abstract][Full Text] [Related]
12. [Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia].
Haddad F; Anouti S; Maalouly G; Jammal M; Nemnoum R; Kettaneh A
Rev Med Interne; 2009 Sep; 30(9):803-5. PubMed ID: 19674818
[TBL] [Abstract][Full Text] [Related]
13. Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia.
Brenner B; Tavori S; Tatarsky I
Haemostasis; 1987; 17(3):141-6. PubMed ID: 3609915
[TBL] [Abstract][Full Text] [Related]
14. Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia.
Steensma DP; Hook CC; Stafford SL; Tefferi A
Br J Haematol; 2002 Sep; 118(3):813-6. PubMed ID: 12181050
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN
Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489
[TBL] [Abstract][Full Text] [Related]
16. Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
Dingli D; Utz JP; Krowka MJ; Oberg AL; Tefferi A
Chest; 2001 Sep; 120(3):801-8. PubMed ID: 11555513
[TBL] [Abstract][Full Text] [Related]
17. Post-splenectomy pseudohyperkalemia in a patient with chronic idiopathic myelofibrosis and thrombocytosis.
Nakhoul F; Ramadan R; Maron M; Abassi Z
Clin Nephrol; 2005 Sep; 64(3):243-6. PubMed ID: 16175953
[No Abstract] [Full Text] [Related]
18. [Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].
Remes K; Pelliniemi TT
Duodecim; 1993; 109(11):983-9. PubMed ID: 8062671
[No Abstract] [Full Text] [Related]
19. [Portal hypertension after splenectomy for myeloid splenomegaly].
Perreau P; Joubaud F; Gardais J; Simard C
Sem Hop; 1972 Jan; 48(5):355-9. PubMed ID: 4339308
[No Abstract] [Full Text] [Related]
20. Portal hypertension complicating myelofibrosis: reversal following splenectomy.
Lukie BE; Card RT
Can Med Assoc J; 1977 Oct; 117(7):771-2. PubMed ID: 907949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
